LONG BEACH, CA - March 11, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource detailing ...
TMS uses electromagnetic induction to stimulate neurons, similar to how a wireless charger transfers energy. The FDA has cleared TMS for Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder ...
LONG BEACH, CA - March 06, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new resource on its ...
Late-life depression (LLD) is a frequent complication of the aging process, occurring in up to 5% of senior adults and in a higher proportion of subjects with coexistent medical illnesses. The average ...
For the many patients with depression who haven't found relief through medication, transcranial magnetic stimulation (TMS) — a noninvasive therapy that uses magnetic pulses to stimulate ...
TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...
A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be a cost-effective treatment option for the NHS in treating moderate and ...
Repetitive transcranial magnetic stimulation (rTMS) and other targeted, noninvasive neuromodulation approaches offer promise for treating neuropsychiatric conditions. These techniques work by ...
Moment of Clarity has published a new educational resource titled “Acccelerated TMS Therapy for Depression“, providing an in-depth look at how transcranial magnetic stimulation (TMS) technology is ...
Soterix Medical Inc., the global leader in non-invasive stimulation and integrated brain monitoring technologies, announced today clearance from the U.S. Food & Drug Administration (FDA) for the SPRY ...